Bharat Immunologicals & Biologicals Corporation Limited
BIBCL.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$376.96M
Close$
Share Statistics
| Market cap | $376.96 Million |
|---|---|
| Enterprise Value | $1.11 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.85 |
| Beta | 0.46 |
| Outstanding Shares | 43,142,982 |
Return
| Return on Equity | -22.95% |
|---|---|
| Return on Assets | -9.60% |
| Return on Invested Capital | -19.28% |
Valuation & Multiples
| P/E Ratio | -2.27 |
|---|---|
| PEG | -3.81 |
| Price to Sales | 9.02 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | 14.46 |
| Enterprise Value to EBIT | -6.44 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bharat Immunologicals & Biologicals Corporation Limited
0
CEO: Dhananjay Kumar Tiwary Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc ...